AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer

Abstract Background The prognostic role of either forkhead box A1 (FOXA1) or anterior gradient 2 (AGR2) in breast cancer has been found separately. Considering that there were interplays between them depending on ER status, we aimed to assess the statistical interaction between AGR2 and FOXA1 on bre...

Full description

Bibliographic Details
Main Authors: Meng Zhou, Xing-li Gan, Yue-xiang Ren, Qian-xin Chen, Yuan-zhong Yang, Zi-jin Weng, Xiao-fang Zhang, Jie-xia Guan, Lu-ying Tang, Ze-fang Ren
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-023-10964-6
_version_ 1797559051256594432
author Meng Zhou
Xing-li Gan
Yue-xiang Ren
Qian-xin Chen
Yuan-zhong Yang
Zi-jin Weng
Xiao-fang Zhang
Jie-xia Guan
Lu-ying Tang
Ze-fang Ren
author_facet Meng Zhou
Xing-li Gan
Yue-xiang Ren
Qian-xin Chen
Yuan-zhong Yang
Zi-jin Weng
Xiao-fang Zhang
Jie-xia Guan
Lu-ying Tang
Ze-fang Ren
author_sort Meng Zhou
collection DOAJ
description Abstract Background The prognostic role of either forkhead box A1 (FOXA1) or anterior gradient 2 (AGR2) in breast cancer has been found separately. Considering that there were interplays between them depending on ER status, we aimed to assess the statistical interaction between AGR2 and FOXA1 on breast cancer prognosis and examine the prognostic role of the combination of them by ER status. Methods AGR2 and FOXA1 expression in tumor tissues were evaluated with tissue microarrays by immunohistochemistry in 915 breast cancer patients with follow up data. The expression levels of these two markers were treated as binary variables, and many different cutoff values were tried for each marker. Survival and Cox proportional hazard analyses were used to evaluate the relationship between AGR2, FOXA1 and prognosis, and the statistical interaction between them on the prognosis was assessed on multiplicative scale. Results Statistical interaction between AGR2 and FOXA1 on the PFS was significant with all the cutoff points in ER-positive breast cancer patients but not ER-negative ones. Among ER-positive patients, the poor prognostic role of the high level of FOXA1 was significant only in patients with the low level of AGR2, and vice versa. When AGR2 and FOXA1 were considered together, patients with low levels of both markers had significantly longer PFS compared with all other groups. Conclusions There was a statistical interaction between AGR2 and FOXA1 on the prognosis of ER-positive breast cancer. The combination of AGR2 and FOXA1 was a more useful marker for the prognosis of ER-positive breast cancer patients.
first_indexed 2024-03-10T17:40:14Z
format Article
id doaj.art-d86d0ca8b1ca4c66ae4f2beb866cd157
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-03-10T17:40:14Z
publishDate 2023-08-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-d86d0ca8b1ca4c66ae4f2beb866cd1572023-11-20T09:44:10ZengBMCBMC Cancer1471-24072023-08-0123111110.1186/s12885-023-10964-6AGR2 and FOXA1 as prognostic markers in ER-positive breast cancerMeng Zhou0Xing-li Gan1Yue-xiang Ren2Qian-xin Chen3Yuan-zhong Yang4Zi-jin Weng5Xiao-fang Zhang6Jie-xia Guan7Lu-ying Tang8Ze-fang Ren9School of Public Health, Sun Yat-Sen UniversitySchool of Public Health, Sun Yat-Sen UniversityThe Third Affiliated Hospital, Sun Yat-Sen UniversitySchool of Public Health, Sun Yat-Sen UniversityThe Sun Yat-sen University Cancer CenterThe Third Affiliated Hospital, Sun Yat-Sen UniversityThe Third Affiliated Hospital, Sun Yat-Sen UniversityThe Third Affiliated Hospital, Sun Yat-Sen UniversityThe Third Affiliated Hospital, Sun Yat-Sen UniversitySchool of Public Health, Sun Yat-Sen UniversityAbstract Background The prognostic role of either forkhead box A1 (FOXA1) or anterior gradient 2 (AGR2) in breast cancer has been found separately. Considering that there were interplays between them depending on ER status, we aimed to assess the statistical interaction between AGR2 and FOXA1 on breast cancer prognosis and examine the prognostic role of the combination of them by ER status. Methods AGR2 and FOXA1 expression in tumor tissues were evaluated with tissue microarrays by immunohistochemistry in 915 breast cancer patients with follow up data. The expression levels of these two markers were treated as binary variables, and many different cutoff values were tried for each marker. Survival and Cox proportional hazard analyses were used to evaluate the relationship between AGR2, FOXA1 and prognosis, and the statistical interaction between them on the prognosis was assessed on multiplicative scale. Results Statistical interaction between AGR2 and FOXA1 on the PFS was significant with all the cutoff points in ER-positive breast cancer patients but not ER-negative ones. Among ER-positive patients, the poor prognostic role of the high level of FOXA1 was significant only in patients with the low level of AGR2, and vice versa. When AGR2 and FOXA1 were considered together, patients with low levels of both markers had significantly longer PFS compared with all other groups. Conclusions There was a statistical interaction between AGR2 and FOXA1 on the prognosis of ER-positive breast cancer. The combination of AGR2 and FOXA1 was a more useful marker for the prognosis of ER-positive breast cancer patients.https://doi.org/10.1186/s12885-023-10964-6Breast cancerPrognosisAGR2FOXA1
spellingShingle Meng Zhou
Xing-li Gan
Yue-xiang Ren
Qian-xin Chen
Yuan-zhong Yang
Zi-jin Weng
Xiao-fang Zhang
Jie-xia Guan
Lu-ying Tang
Ze-fang Ren
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
BMC Cancer
Breast cancer
Prognosis
AGR2
FOXA1
title AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
title_full AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
title_fullStr AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
title_full_unstemmed AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
title_short AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
title_sort agr2 and foxa1 as prognostic markers in er positive breast cancer
topic Breast cancer
Prognosis
AGR2
FOXA1
url https://doi.org/10.1186/s12885-023-10964-6
work_keys_str_mv AT mengzhou agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT xingligan agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT yuexiangren agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT qianxinchen agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT yuanzhongyang agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT zijinweng agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT xiaofangzhang agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT jiexiaguan agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT luyingtang agr2andfoxa1asprognosticmarkersinerpositivebreastcancer
AT zefangren agr2andfoxa1asprognosticmarkersinerpositivebreastcancer